Showing results (1711-1720 of 3,014) with videos related to

Sort By:
Pageof 302
Urology|August 16, 2005
The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: a Phase II feasibility study conducted by the Hellenic Cooperative Oncology GroupGeorgios Fotios Samelis, Haralambos Kalofonos, Adamos Adamou, et al.
European Urology|January 1, 1997
Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group studyD V Skarlos, G Aravantinos, E Linardou, et al.
Haematologica|December 18, 2012
Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trialMeletios A Dimopoulos, Michel Delforge, Roman Hájek, et al.
American Journal of Hematology|June 13, 2013
Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimensTina Bagratuni, Efstathios Kastritis, Marianna Politou, et al.
Elife|December 6, 2017
An Aedes aegypti-associated fungus increases susceptibility to dengue virus by modulating gut trypsin activityYesseinia I Angleró-Rodríguez, Octavio Ac Talyuli, Benjamin J Blumberg, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 23, 2020
Response of an oncology unit in the midst of the COVID-19 outbreakMichalis Liontos, Efstathios Kastritis, Magdalini Migkou, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 4, 2019
Expression of S100B Protein in Ischemia/Reperfusion-Induced Brain Injury After Cyclosporine Therapy: A Biochemical Serum Marker with Prognostic Value?Christos Dimopoulos, Christos Damaskos, Marios Papadakis, et al.
International Journal of Cardiology|August 3, 2019
A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot studyHeba Nashat, Aleksander Kempny, Carl Harries, et al.
Physiological Research|January 18, 2008
Ischemic preconditioning fails to confer additional protection against ischemia-reperfusion injury in the hypothyroid rat heartI Mourouzis, A Dimopoulos, T Saranteas, et al.
Journal of Clinical Medicine|September 28, 2021
Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-AnalysesRebecca Georgakopoulou, Oraianthi Fiste, Theodoros N Sergentanis, et al.
Pageof 302